Campbell & Co Investment Adviser’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-78,345	Closed	-$2.03M	–	1336
2025 Q4	$2.03M	Buy	+78,345	New	+$1.86M	0.1%	331
2024 Q4	–	Sell	-18,913	Closed	-$285K	–	1288
2024 Q3	$285K	Buy	18,913 +1,639	+9%	+$28K	0.02%	924
2024 Q2	$494K	Buy	17,274 +4,569	+36%	+$130K	0.04%	660
2024 Q1	$371K	Sell	12,705 -12,726	-50%	-$391K	0.03%	827
2023 Q4	$858K	Buy	25,431 +17,432	+218%	+$510K	0.08%	456
2023 Q3	$245K	Buy	+7,999	New	+$288K	0.03%	794
2023 Q2	–	Sell	-14,087	Closed	-$575K	–	1063
2023 Q1	$575K	Sell	14,087 -7,429	-35%	-$296K	0.11%	366
2022 Q4	$831K	Buy	+21,516	New	+$1.05M	0.2%	136
2022 Q3	–	Sell	-21,511	Closed	-$1.25M	–	872
2022 Q2	$1.25M	Buy	+21,511	New	+$1.41M	0.34%	43
2022 Q1	–	Sell	-9,566	Closed	-$576K	–	853
2021 Q4	$576K	Buy	+9,566	New	+$527K	0.2%	159